Lemaitre Vascular (LMAT) Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Operating Expenses data on file, last reported at $30.6 million in Q1 2026.

• Quarterly Operating Expenses rose 6.35% year-over-year to $30.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.5 million (up 9.55% YoY) and the FY2025 annual result came in at $110.6 million, up 12.15% from the prior year.
• Operating Expenses improved to $30.6 million in Q1 2026 per LMAT's latest filing, from $27.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $30.6 million in Q1 2026 and bottomed at $18.0 million in Q1 2022.
• The 5-year median for Operating Expenses is $24.0 million (2024), against an average of $24.0 million.
• The widest annual swing landed in 2022, when Operating Expenses soared 40.7%; it then rose 2.76% in 2023.
• Tracing LMAT's Operating Expenses over 5 years: stood at $19.1 million in 2022, then increased by 20.81% to $23.1 million in 2023, then advanced by 11.61% to $25.7 million in 2024, then increased by 6.3% to $27.4 million in 2025, then advanced by 11.93% to $30.6 million in 2026.
• Per Business Quant, the three latest LMAT Operating Expenses figures stand at $30.6 million (Q1 2026), $27.4 million (Q4 2025), and $25.6 million (Q3 2025).

Peer Comparison